Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Sorafenib tosylate

EU orphan designation number: EU/3/13/1199   
Active ingredient: Sorafenib tosylate
Indication: Treatment of follicular thyroid cancer
Sponsor: Bayer Pharma AG
Müllerstrasse 178, 13353 Berlin, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Centralised Orphan - Designation EMA/OD/092/13 (2013)8045 of 13/11/2013
30/05/2014 Centralised Orphan - Change of address